Chemo #3, Young Mom with Small kids – shows wig, bald head
I just finished chemo #3 of 4. Today I don’t feel so bad, but we’ll see what happens over the next few days. I’m so not looking forward to that. Heres a little video describing my day today and the weekend to come. At one point Evan and Noah join me in the video as well. We show off our Livestrong bracelets and I mention the fun I’ve been having keeping up with Livestrong vs Stillerstrong. Hey Lance and Ben, I’d be glad to wear your stuff on my videos. Let me know. thanks everyone for your support while I beat this meanie breast cancer.
iS CANCER CARE Program Heals Skin from Head to Soul
iS CANCER CARE Program Heals Skin from Head to Soul
Each October, Innovative Skincare organizes its annual iS CANCER CARE Spa Days, where volunteers, including dermatologists, medical aestheticians, massage therapists, and others from UCLA/Revlon Breast Cancer Center and the Washington Cancer Institute at Washington Hospital Center give special treatments to participants in the iS CANCER CARE Program. This year’s events are October 9th at …
Read more on PRWeb via Yahoo! News
Head and Neck Cancer – To The Best of My Knowledge
wpsu.org Graham Spanier discusses head and neck cancer with guest David Goldenberg, MD
BioVex Announces Publication of Head and Neck Cancer Clinical Trial Results with OncoVEX GM-CSF in the Journal …
BioVex Announces Publication of Head and Neck Cancer Clinical Trial Results with OncoVEX GM-CSF in the Journal …
WOBURN, Mass. & OXFORD, England–(BUSINESS WIRE)–Clinical Cancer Research Publication
Read more on Business Wire
Categories: Breast Cancer Radiation Tags: Announces, BioVex, cancer, Clinical, GMCSF, Head, Journal, neck, OncoVEX, Publication, Results, Trial
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
WOBURN, Mass.—-BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and the prevention of infectious disease, announced today that it has appointed Dr Kapil Dhingra to the Board of Directors as a Non-Executive.
Read more on Business Wire via Yahoo! Finance